Climodien^® (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints

By Gräser T.   Römer T.   Wiedey K. D.   Janaud A.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 332-342

Informa Healthcare

Access to resources Recommend Favorite

A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

By Endrikat Jan   Lange Evelyn   Kunz Michael   Schmidt Werner   Graeser Thomas  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 229-239

Informa Healthcare

Access to resources Recommend Favorite

1 and 2 mg 17β-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women

By Stevenson J. C.   Rioux J. E.   Komer L.   Gelfand M.  

Climacteric, Vol. 8, Iss. 4, 2005-12 ,pp. : 352-359

Informa Healthcare

Access to resources Recommend Favorite

Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women

By Lin S-Q.   Sun L-Z.   Lin J-F.   Yang X.   Zhang L-J.   Qiao J.   Wang Z-H.   Xu Y-X.   Xiong Z-A.   Zhou Y-Z.   Wang M-L.   Zhu J.   Chen S-R.   Su H.   Yang C-S.   Wang S-H.   Zhang Y-Z.   Dong X-J.  

Climacteric, Vol. 14, Iss. 4, 2011-08 ,pp. : 472-481

Informa Healthcare

Access to resources Recommend Favorite

Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17β-estradiol combined with sequential 5-20 mg dydrogesterone

By Ferenczy A.   Gelfand M. M.   van de Weijer P. H. M.   Rioux J. E.  

Climacteric, Vol. 5, Iss. 1, 2002-03 ,pp. : 26-35

Informa Healthcare

Access to resources Recommend Favorite